Posted on: 08-02-2021
Back to overviewSTERIS is pleased to announce it has agreed to sell the pharmaceutical testing services business of Synergy Health Utrecht B.V., a STERIS Company, to CCR Group, an integrated contract research organization, part of FIELDS Group.
The transaction includes the chemical testing laboratory in Utrecht and the microbiological testing for pharmaceuticals in Ede the Netherlands. STERIS will continue to operate the laboratory in Ede with a focus on medical device testing. The acquisition is completed by FIELDS’ contract research organization (CRO) platform, CCR Group. As part of the agreement, CCR Group will carve-out the company from STERIS and move the laboratories to a new state-of-the-art laboratory facility in the Netherlands.
“I am pleased we found a very good new owner for the business in CCR Group, which was of paramount importance to STERIS. I am looking forward to growing our relationship going forward,” said Mark Botting, STERIS Director of Global Laboratories.
“With the acquisition of Synergy Health Utrecht B.V., the CCR Group strategically expands its portfolio into the field of chemical and microbiological analytics. As part of our growth plan, we expect to acquire more CROs in adjacent areas in the near future,” said Matthias Stuckmann, responsible manager for CCR Group.
About STERIS
STERIS’s MISSION IS TO HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science product and service solutions around the globe. For more information, visit www.steris-ast.com
About CCR Group
CCR Group is a European CRO with laboratory sites in Germany and the Netherlands offering a comprehensive set of integrated services to predominantly the pharmaceutical and biotech industries. Through its subsidiary ICCR-Roßdorf (www.iccr-rossdorf.de), the group currently offers expertise into preclinical safety testing with focus on cell and molecular science assays according to GLP, GMP and DIN EN ISO 17025.
About FIELDS Group
FIELDS Group is an entrepreneurial and hands-on investor with offices in Amsterdam and Munich. With its in-house operational taskforce, FIELDS Group is directly involved with the development of the group companies. It has a strong track record in successfully carving-out companies from large (listed) corporations.
